-
2,7-Dichlorodihydrofluorescein diacetate for ROS
2026-08-19
Build more informative oxidative-stress experiments with DCFH-DA across granulosa-cell, mitochondrial, and drug-screening models. This guide combines a practical loading workflow with controls that help distinguish genuine intracellular ROS changes from probe, optical, and cytotoxicity artifacts.
-
Tofacitinib Workflows for RA Macrophage Research
2026-08-19
Tofacitinib, or CP-690550, helps connect JAK/STAT5 inhibition with inflammatory phenotype, mitochondrial structure, and metabolic recovery in GM-CSF-conditioned rheumatoid arthritis macrophages. This practical workflow emphasizes dose-ranging, pathway-proximal validation, orthogonal readouts, and troubleshooting that separates cytokine signaling blockade from nonspecific toxicity.
-
HyperScribe T7 High Yield Cy5 RNA Labeling Kit Guide
2026-08-18
Build fluorescent RNA probes for in situ hybridization, Northern blot hybridization, and delivery-tracking experiments with a tunable Cy5-UTP workflow. This guide connects labeling-density control with practical assay design, including how to distinguish probe localization from functional mRNA delivery.
-
Neurotensin: Assay Design Beyond GPCR Trafficking
2026-08-18
Neurotensin research benefits from more than receptor activation alone. This guide presents an interference-aware framework for linking NTR1 signaling, miR-133α modulation, receptor trafficking, and reproducible gastrointestinal cell assays.
-
P2Y11 Antagonist NF 340: Assay Workflows
2026-08-17
NF 340 provides a rapid pharmacological way to interrogate P2Y11-linked GPCR signaling alongside migration, invasion, and phospho-myosin readouts. This guide translates breast cancer evidence into practical assay design, fresh-solution handling, dose-finding, and troubleshooting strategies.
-
Thiothixene Drives Continual Macrophage Efferocytosis
2026-08-17
The reference study identifies Thiothixene as an established typical antipsychotic agent that enhances the clearance of apoptotic and lipid-laden cells by mouse and human macrophages. Its proposed mechanism involves Stra6L, vitamin A signaling, and Arginase 1, while the study also reveals an inhibitory role for dopamine in macrophage efferocytosis.
-
LY2603618: Chk1 Inhibitor Workflow for DDR Studies
2026-08-16
LY2603618 enables mechanism-focused studies of Chk1 inhibition, DNA damage accumulation, and cell-cycle disruption across cancer models. This workflow combines practical dosing guidance with patient-specific assay design inspired by an iPSC-based clinical trial selection platform.
-
Removing Pollen Interference in Hazardous Aerosol Detection
2026-08-15
Zhang and colleagues developed a fluorescence-data workflow that reduces pollen interference when classifying hazardous bioaerosol components. Combining spectral transformations, especially fast Fourier transform, with random forest classification improved recognition of pathogens and toxins and supports more reliable rapid aerosol monitoring.
-
Nonselective β-Blockade Delays HCT Recovery
2026-08-14
The reference study shows that nonselective β-adrenergic receptor inhibition can impair hematopoietic regeneration after allogeneic hematopoietic cell transplantation (HCT), whereas β1-selective blockade with metoprolol did not produce the same defect. By integrating mouse transplantation experiments with analyses of human HCT cohorts, the work identifies β-blocker selectivity as a clinically relevant variable in post-transplant engraftment.
-
Myriocin Workflow for Sphingolipid Research
2026-08-14
Myriocin enables direct, experimentally tractable control of de novo sphingolipid biosynthesis for cancer, immunology, and brain-lipid studies. This workflow connects SPT inhibition with dose-response design, spatial lipid imaging, target-engagement assays, and practical troubleshooting.
-
Methylprednisolone Sodium Succinate: Research Workflows
2026-08-13
Build controlled inflammation, cytokine, ROS, chemotaxis, and apoptosis experiments around a water-compatible synthetic corticosteroid. This guide emphasizes concentration-window mapping, time-course design, translational injury models, and practical troubleshooting for reproducible bench research.
-
In Vitro Mammalian Embryonic Dormancy via mTOR Inhibition
2026-08-13
This Nature Protocols study translates embryonic diapause into reversible in vitro systems using pharmacological mTOR inhibition in mouse blastocysts, human blastoids, and pluripotent stem cells. Its main contribution is a practical, noninvasive framework for inducing, releasing, and evaluating dormancy while preserving developmental potential, although model-specific validation remains essential.
-
MK-0812 Workflows for Gut–Liver Inflammation
2026-08-12
This guide translates selective CCR2 blockade into practical whole-blood, monocyte-trafficking, and gut–liver-axis experiments. It combines MK-0812 pharmacology with the TM6SF2–MASH model to help researchers separate monocyte recruitment effects from epithelial, microbial, and lipid-signaling changes.
-
Aprotinin for RBC Membrane Research
2026-08-12
Aprotinin provides a practical way to separate serine-protease activity from membrane mechanics, fibrinolysis, and inflammatory readouts. This workflow connects bovine pancreatic trypsin inhibitor use with red blood cell membrane studies while highlighting controls, preparation choices, and interpretation limits.
-
T0070907: A Mechanistic Probe of PPARγ Signaling
2026-08-11
T0070907 is a covalent PPARγ antagonist for dissecting receptor-dependent transcription, adipogenesis inhibition, and cell-cycle responses. This guide connects its molecular pharmacology with the RXRα/PPARγ/NEDD4 axis while emphasizing assay design, controls, and interpretation.